Similar articles for PMID: 30378545

Year	Number of Results
1996	1
1997	1
2000	1
2006	2
2007	3
2008	2
2009	3
2010	3
2011	3
2012	1
2013	2
2014	2
2015	6
2016	12
2017	22
2018	16
2019	10
2020	4
2021	2
2024	0

1

Psoriasis induced by trastuzumab therapy.

de Lorenzi C, Kaya G, Quenan S. de Lorenzi C, et al. Eur J Dermatol. 2018 Oct 1;28(5):702-704. doi: 10.1684/ejd.2018.3395. Eur J Dermatol. 2018. PMID: 30378545 No abstract available.

2

Corneal Changes in Trastuzumab Emtansine Treatment.

Kreps EO, Derveaux T, Denys H. Kreps EO, et al. Clin Breast Cancer. 2018 Aug;18(4):e427-e429. doi: 10.1016/j.clbc.2018.03.005. Epub 2018 Mar 12. Clin Breast Cancer. 2018. PMID: 29615304 No abstract available.

3

A case of trastuzumab-induced dermatomyositis.

Trontzas IP, Syrigos NK, Kotteas EA. Trontzas IP, et al. J Cancer Res Ther. 2021 Jul-Sep;17(4):1112-1114. doi: 10.4103/jcrt.JCRT_209_19. J Cancer Res Ther. 2021. PMID: 34528573 Free article.

4

A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer.

Stoen E, Kabos P, Borden KC, Brown RJ, Borges VF, Diamond JR. Stoen E, et al. Oncology (Williston Park). 2018 Jun;32(6):298-302. Oncology (Williston Park). 2018. PMID: 29940061 Free article. No abstract available.

5

Can estrogen receptor status predict for shorter duration of adjuvant trastuzumab in early-stage breast cancer?

Mathew A, Erqou S. Mathew A, et al. Ann Oncol. 2018 Dec 1;29(12):2391-2392. doi: 10.1093/annonc/mdy478. Ann Oncol. 2018. PMID: 30357315 Free article. No abstract available.

6

Thrombocytopenia Induced by Herceptin.

Luo Q, Guo Z, Ye C. Luo Q, et al. Am Surg. 2019 Apr 1;85(4):e222-e224. Am Surg. 2019. PMID: 31043221 No abstract available.

7

Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study.

Gong IY, Verma S, Yan AT, Ko DT, Earle CC, Tomlinson GA, Trudeau ME, Krahn MD, Krzyzanowska MK, Brezden-Masley CB, Gavura S, Peacock S, Chan KK. Gong IY, et al. Breast Cancer Res Treat. 2016 Jun;157(3):535-44. doi: 10.1007/s10549-016-3823-y. Epub 2016 Jun 6. Breast Cancer Res Treat. 2016. PMID: 27271767

8

Intrathecal Trastuzumab as a Potential Cause of Drug-Induced Aseptic Meningitis.

Pappa E, Conforti R, Hoang-Xuan K, Alentorn A. Pappa E, et al. Can J Neurol Sci. 2019 May;46(3):358-359. doi: 10.1017/cjn.2019.21. Epub 2019 Mar 25. Can J Neurol Sci. 2019. PMID: 30905325 No abstract available.

9

Irreversible left atrium dilatation preceding left ventricular dysfunction during trastuzumab therapy.

Dolci G, Bergamini C, Fiorio E, Ribichini F. Dolci G, et al. Minerva Cardioangiol. 2018 Apr;66(2):223-224. doi: 10.23736/S0026-4725.17.04483-8. Minerva Cardioangiol. 2018. PMID: 29512363 No abstract available.

10

Predictive markers for trastuzumab-associated cardiac dysfunction in patients with early-stage human epidermal growth factor receptor 2-positive breast cancer receiving trastuzumab.

Altundag K. Altundag K. J BUON. 2017 May-Jun;22(3):801. J BUON. 2017. PMID: 28730792 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

85 results

Results by year